Related Experiment Video
Updated: Oct 1, 2025

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA
Xutao Chen1,2, Zhuo Wan3, Liu Yang2
1Department of Implant Dentistry, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.
Background:
Periodontitis is characterized by progressive inflammation and alveolar bone loss resulting in tooth loss finally. Macrophages including pro-inflammatory M1-like macrophages and reparative M2-like macrophages play a vital role in inflammation and tissue homeostasis in periodontitis. Among them, reparative M2-like macrophages have been shown to promote tissue repair and prevent bone loss. However, the mechanism of reparative M2 macrophages-induced osteoprotective effect remains elusive.
Results:
Exosomes from reparative M2-like macrophages (M2-Exos) were isolated and identified successfully. M2-Exos could promote bone marrow stromal cells (BMSCs) osteogenic differentiation while suppressing bone marrow derived macrophage (BMDM) osteoclast formation, and prohibit pathological alveolar bone resorption because of the intercellular communication via exosomes. High expression level of IL-10 mRNA was detected not only in reparative M2-like macrophages but also in M2-Exos. Meanwhile, IL-10 expression level in BMSCs or BMDM was also upregulated significantly after co-culturing with M2-Exos in a concentration-dependent manner. In vitro, recombinant IL-10 proteins had the ability to selectively promote osteogenic differentiation of BMSCs and hinder osteoclast differentiation of BMDM. Moreover, after treatment with M2-Exos and IL-10R antibody together, the capacity of promoting osteogenesis and suppressing osteoclastogenesis of M2-Exos was significantly reversed. In vivo experiments further showed that M2-Exos reduced alveolar bone resorption in mice with periodontitis via IL-10/IL-10R pathway.
Conclusion:
In conclusion, our results demonstrate that the reparative M2-like macrophages could promote osteogenesis while inhibiting osteoclastogenesis in vitro as well as protect alveolar bone against resorption in vivo significantly. M2-Exos could upregulate the IL-10 cytokines expression of BMSCs and BMDM via delivering exosomal IL-10 mRNA to cells directly, leading to activation of the cellular IL-10/IL-10R pathway to regulate cells differentiation and bone metabolism. These results might partly account for the mechanism of osteoprotective effect of reparative M2-like macrophages and provide a novel perspective and a potential therapeutic approach on improving alveolar resorption by M2-Exos.
Insights
Reparative M2 macrophage-derived exosomes (M2-Exos) promote bone formation and inhibit bone loss in periodontitis by delivering IL-10 mRNA. This study reveals M2-Exos as a potential therapeutic strategy for alveolar bone resorption.
Area of Science:
- Cell Biology
- Immunology
- Regenerative Medicine
Background:
- Periodontitis involves inflammation and alveolar bone loss, potentially leading to tooth loss.
- Macrophages, particularly M2-like macrophages, play a role in tissue homeostasis and repair during periodontitis.
- The osteoprotective mechanism of M2-like macrophages remains unclear.
Purpose of the Study:
- To investigate the mechanism by which reparative M2-like macrophages protect against alveolar bone loss.
- To explore the role of exosomes derived from M2-like macrophages (M2-Exos) in regulating bone metabolism.
- To elucidate the involvement of the IL-10/IL-10R pathway in M2-Exos-mediated osteoprotection.
Main Methods:
- Isolation and identification of exosomes from M2-like macrophages (M2-Exos).
- In vitro co-culture assays with bone marrow stromal cells (BMSCs) and bone marrow-derived macrophages (BMDMs).
- Assessment of osteogenic and osteoclastogenic differentiation.
- In vivo studies in a mouse model of periodontitis.
- Analysis of IL-10 mRNA and protein expression, and IL-10 receptor (IL-10R) antibody blocking experiments.
Main Results:
- M2-Exos promoted osteogenic differentiation of BMSCs and suppressed osteoclast formation from BMDMs, thereby inhibiting alveolar bone resorption.
- M2-Exos delivered IL-10 mRNA to BMSCs and BMDMs, upregulating IL-10 expression and activating the IL-10/IL-10R pathway.
- In vivo, M2-Exos treatment significantly reduced alveolar bone loss in periodontitis-induced mice via the IL-10/IL-10R pathway.
Conclusions:
- Reparative M2-like macrophages and their derived exosomes (M2-Exos) exert osteoprotective effects by promoting osteogenesis and inhibiting osteoclastogenesis.
- M2-Exos mediate their effects by transferring IL-10 mRNA, activating the IL-10/IL-10R pathway in recipient cells, and regulating bone metabolism.
- M2-Exos represent a promising therapeutic agent for periodontitis and alveolar bone resorption.

